May 13, 2026 06:05AM
May 12, 2026 07:07AM
May 12, 2026 07:05AM
May 5, 2026 07:00AM
Feb 24, 2026 07:08AM
Feb 24, 2026 07:00AM
Feb 17, 2026 07:00AM Arvinas to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Jan 8, 2026 04:30PM
Jan 8, 2026 04:30PM
Nov 5, 2025 07:18AM
Nov 5, 2025 07:00AM
Oct 29, 2025 07:00AM
Aug 7, 2025 06:53AM
Aug 6, 2025 07:50AM Arvinas, Inc. (ARVN) Tops Q2 EPS by 10c
Aug 6, 2025 07:00AM
Jul 30, 2025 04:05PM
May 31, 2025 08:00AM
May 31, 2025 08:00AM
May 2, 2025 05:35AM
May 1, 2025 07:07AM
May 1, 2025 07:00AM Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update
Apr 28, 2025 07:00AM
Mar 11, 2025 06:46AM
Mar 11, 2025 06:45AM
Feb 11, 2025 07:03AM
Feb 11, 2025 07:00AM
Feb 3, 2025 07:00AM
Dec 10, 2024 09:09AM Arvinas (ARVN) and Pfizer (PFE) Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium
Dec 10, 2024 09:05AM
Oct 30, 2024 07:11AM
Oct 30, 2024 07:00AM
Oct 21, 2024 07:00AM
Oct 1, 2024 06:47AM
Jul 30, 2024 09:30AM
Jul 30, 2024 07:00AM Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update
May 16, 2024 06:01AM
May 16, 2024 06:00AM
May 7, 2024 07:33AM
May 7, 2024 07:00AM
Feb 27, 2024 07:00AM
Feb 6, 2024 06:46AM
Feb 6, 2024 06:45AM Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer
Dec 5, 2023 01:36PM
Dec 5, 2023 01:33PM
Nov 28, 2023 05:05PM
Nov 7, 2023 07:21AM
Nov 7, 2023 07:00AM
Oct 15, 2023 06:05PM
Aug 8, 2023 07:02AM Arvinas, Inc. (ARVN) Tops Q2 EPS by 40c
Aug 8, 2023 07:00AM

1,199,634 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All